Stock Watch: Dashing Great GLP-1 Agonist Expectations
Lilly And Novo Nordisk Results Suffer From Forecasts – And Election Result
Novo Nordisk learned from missing analysts’ estimates after its second-quarter report but Eli Lilly was caught this time round. Meanwhile, a falling tide grounded all ships after the US election.
